BenevolentAI

BenevolentAI is the global leader in the development and application of artificial intelligence (“AI”) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world’s 8,000 untreated diseases. Our team of technologists, AI researchers, and scientists build and applies AI to the entire drug discovery and development process.